Works matching IS 08876924 AND DT 2008 AND VI 22 AND IP 7

Results: 29

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1428, doi. 10.1038/sj.leu.2405060
By:
- Hasle, H;
- Abrahamsson, J;
- Arola, M;
- Karow, A;
- O'Marcaigh, A;
- Reinhardt, D;
- Webb, D K H;
- van Wering, E;
- Zeller, B;
- Zwaan, C M;
- Vyas, P
Publication type:
Article
Sirolimus enhances the effect of apoptotic cell infusion on hematopoietic engraftment and tolerance induction.
Published in:
2008
By:
- Bonnefoy, F;
- Masson, E;
- Perruche, S;
- Marandin, A;
- Borg, C;
- Radlovic, A;
- Shipman, B;
- Tiberghien, P;
- Saas, P;
- Kleinclauss, F
Publication type:
Letter
Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1434, doi. 10.1038/sj.leu.2405063
By:
- Van Vlierberghe, P;
- Beverloo, H B;
- Buijs-Gladdines, J;
- van Wering, E R;
- Horstmann, M;
- Pieters, R;
- Meijerink, J P P
Publication type:
Article
Induction of Toll-like receptor 2 and 4 expression on CD4+ and CD8+ T cells in G-CSF-mobilized unrelated peripheral blood stem cell grafts during leukapheresis: impact on patient outcome.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1438, doi. 10.1038/sj.leu.2405075
By:
- Platzbecker, U;
- Stoehlmacher, J;
- Pabst, C;
- Goekkurt, E;
- Oelschlägel, U;
- Schirutschke, H;
- Hölig, K;
- Theuser, C;
- Mogck, U;
- Ehninger, G;
- Bornhäuser, M
Publication type:
Article
Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1446, doi. 10.1038/sj.leu.2405077
By:
- Stamatopoulos, K;
- Papadaki, T;
- Pontikoglou, C;
- Athanasiadou, I;
- Stavroyianni, N;
- Bux, J;
- Batsis, I;
- Pyrovolaki, K;
- Paterakis, G;
- Anagnostou, D;
- Anagnostopoulos, A;
- Papadaki, H A
Publication type:
Article
Inhibition of MEK/ERK signaling synergistically potentiates histone deacetylase inhibitor-induced growth arrest, apoptosis and acetylation of histone H3 on p21waf1 promoter in acute myelogenous leukemia cell.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1449, doi. 10.1038/sj.leu.2405079
By:
- Nishioka, C;
- Ikezoe, T;
- Yang, J;
- Koeffler, H P;
- Yokoyama, A
Publication type:
Article
MicroRNA expression in lymphocyte development and malignancy.
Published in:
2008
By:
- Lawrie, C H;
- Saunders, N J;
- Soneji, S;
- Palazzo, S;
- Dunlop, H M;
- Cooper, C D O;
- Brown, P J;
- Troussard, X;
- Mossafa, H;
- Enver, T;
- Pezzella, F;
- Boultwood, J;
- Wainscoat, J S;
- Hatton, C S R
Publication type:
Letter
Tandutinib inhibits FMS receptor signalling, and macrophage and osteoclast formation in vitro.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1452, doi. 10.1038/sj.leu.2405085
By:
- Brownlow, N;
- Vaid, M;
- Dibb, N J
Publication type:
Article
JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1454, doi. 10.1038/sj.leu.2405088
By:
- Cambier, N;
- Renneville, A;
- Cazaentre, T;
- Soenen, V;
- Cossement, C;
- Giraudier, S;
- Grardel, N;
- Laï, J-L;
- Rose, C;
- Preudhomme, C
Publication type:
Article
A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL.
Published in:
2008
By:
- Best, O G;
- Gardiner, A C;
- Majid, A;
- Walewska, R;
- Austen, B;
- Skowronska, A;
- Ibbotson, R;
- Stankovic, T;
- Dyer, M J S;
- Oscier, D G
Publication type:
Letter
NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?
Published in:
2008
By:
- Pasqualucci, L;
- Li, S;
- Meloni, G;
- Schnittger, S;
- Gattenlohner, S;
- Liso, A;
- Di Ianni, M;
- Martelli, M P;
- Pescarmona, E;
- Foa, R;
- Haferlach, T;
- Skoda, R C;
- Falini, B
Publication type:
Case Study
Two cases of hypereosinophilia and high-risk acute lymphoblastic leukemia.
Published in:
2008
By:
- Sutton, R;
- Lonergan, M;
- Tapp, H;
- Venn, N C;
- Haber, M;
- Norris, M D;
- O'Brien, T A;
- Alvaro, F;
- Revesz, T
Publication type:
Case Study
Preclinical targeting of NF-κB and FLT3 pathways in AML cells.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1466, doi. 10.1038/sj.leu.2405102
By:
- Griessinger, E;
- Frelin, C;
- Cuburu, N;
- Imbert, V;
- Dageville, C;
- Hummelsberger, M;
- Sirvent, N;
- Dreano, M;
- Peyron, J-F
Publication type:
Article
Genomic and molecular switching in relapsed acute promyelocytic leukemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1469, doi. 10.1038/sj.leu.2405103
By:
- Albano, F;
- Pannunzio, A;
- Anelli, L;
- Zagaria, A;
- Liso, V;
- Rocchi, M;
- Specchia, G
Publication type:
Article
Is BAL useful in patients with acute myeloid leukemia admitted in ICU for severe respiratory complications?
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1361, doi. 10.1038/leu.2008.100
By:
- Rabbat, A;
- Chaoui, D;
- Lefebvre, A;
- Roche, N;
- Legrand, O;
- Lorut, C;
- Rio, B;
- Marie, J-P;
- Huchon, G
Publication type:
Article
Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1368, doi. 10.1038/leu.2008.112
By:
- Puigdecanet, E;
- Espinet, B;
- Lozano, J J;
- Sumoy, L;
- Bellosillo, B;
- Arenillas, L;
- Álvarez-Larrán, A;
- Solé, F;
- Serrano, S;
- Besses, C;
- Florensa, L
Publication type:
Article
Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1299, doi. 10.1038/leu.2008.113
By:
- Vannucchi, A M;
- Antonioli, E;
- Guglielmelli, P;
- Pardanani, A;
- Tefferi, A
Publication type:
Article
The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1308, doi. 10.1038/leu.2008.119
By:
- Orazi, A;
- Germing, U
Publication type:
Article
Treatment of plasma cell dyscrasias with lenalidomide.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1343, doi. 10.1038/leu.2008.123
By:
- Dimopoulos, M A;
- Kastritis, E;
- Rajkumar, S V
Publication type:
Article
Resistance to FLT3 inhibition in an in vitro model of primary AML cells with a stem cell phenotype in a defined microenvironment.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1395, doi. 10.1038/leu.2008.125
By:
- Mony, U;
- Jawad, M;
- Seedhouse, C;
- Russell, N;
- Pallis, M
Publication type:
Article
Bruton's tyrosine kinase is not essential for Bcr-Abl-mediated transformation of lymphoid or myeloid cells.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1354, doi. 10.1038/leu.2008.126
By:
- MacPartlin, M;
- Smith, A M;
- Druker, B J;
- Honigberg, L A;
- Deininger, M W
Publication type:
Article
Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders.
Published in:
2008
By:
- Walz, C;
- Cross, N C P;
- Van Etten, R A;
- Reiter, A
Publication type:
journal article
Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1335, doi. 10.1038/leu.2008.162
By:
- Emanuel, P D
Publication type:
Article
Evidence suggesting the presence of a stem cell clone anteceding the acquisition of the JAK2-V617F mutation.
Published in:
2008
By:
- Jamal, R;
- Bélisle, C;
- Lessard, M-C;
- Hébert, J;
- Roy, D-C;
- Levine, R;
- Busque, L;
- Bélisle, C;
- Hébert, J
Publication type:
Case Study
Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo.
Published in:
2008
By:
- Shammas, M A;
- Koley, H;
- Bertheau, R C;
- Neri, P;
- Fulciniti, M;
- Tassone, P;
- Blotta, S;
- Protopopov, A;
- Mitsiades, C;
- Batchu, R B;
- Anderson, K C;
- Chin, A;
- Gryaznov, S;
- Munshi, N C
Publication type:
journal article
Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin.
Published in:
2008
By:
- Wu, L X;
- Xu, J H;
- Zhang, K Z;
- Lin, Q;
- Huang, X W;
- Wen, C X;
- Chen, Y Z
Publication type:
journal article
HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1387, doi. 10.1038/leu.2008.90
By:
- Rutten, C E;
- van Luxemburg-Heijs, S A P;
- Griffioen, M;
- Marijt, E W A;
- Jedema, I;
- Heemskerk, M H M;
- Posthuma, E F M;
- Willemze, R;
- Falkenburg, J H F
Publication type:
Article
Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial.
Published in:
Leukemia (08876924), 2008, v. 22, n. 7, p. 1377, doi. 10.1038/leu.2008.96
By:
- Ritgen, M;
- Böttcher, S;
- Stilgenbauer, S;
- Bunjes, D;
- Schubert, J;
- Cohen, S;
- Humpe, A;
- Hallek, M;
- Kneba, M;
- Schmitz, N;
- Döhner, H;
- Dreger, P
Publication type:
Article
VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma.
Published in:
2008
By:
- Pineda-Roman, M;
- Zangari, M;
- van Rhee, F;
- Anaissie, E;
- Szymonifka, J;
- Hoering, A;
- Petty, N;
- Crowley, J;
- Shaughnessy, J;
- Epstein, J;
- Barlogie, B
Publication type:
journal article

Works matching IS 08876924 AND DT 2008 AND VI 22 AND IP 7

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.

Sirolimus enhances the effect of apoptotic cell infusion on hematopoietic engraftment and tolerance induction.

Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia.

Induction of Toll-like receptor 2 and 4 expression on CD4<sup>+</sup> and CD8<sup>+</sup> T cells in G-CSF-mobilized unrelated peripheral blood stem cell grafts during leukapheresis: impact on patient outcome.

Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia.

Inhibition of MEK/ERK signaling synergistically potentiates histone deacetylase inhibitor-induced growth arrest, apoptosis and acetylation of histone H3 on p21<sup>waf1</sup> promoter in acute myelogenous leukemia cell.

MicroRNA expression in lymphocyte development and malignancy.

Tandutinib inhibits FMS receptor signalling, and macrophage and osteoclast formation in vitro.

JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders.

A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL.

NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?

Two cases of hypereosinophilia and high-risk acute lymphoblastic leukemia.

Preclinical targeting of NF-κB and FLT3 pathways in AML cells.

Genomic and molecular switching in relapsed acute promyelocytic leukemia.

Is BAL useful in patients with acute myeloid leukemia admitted in ICU for severe respiratory complications?

Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia.

Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal.

The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features.

Treatment of plasma cell dyscrasias with lenalidomide.

Resistance to FLT3 inhibition in an in vitro model of primary AML cells with a stem cell phenotype in a defined microenvironment.

Bruton's tyrosine kinase is not essential for Bcr-Abl-mediated transformation of lymphoid or myeloid cells.

Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders.

Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.

Evidence suggesting the presence of a stem cell clone anteceding the acquisition of the JAK2-V617F mutation.

Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo.

Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin.

HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia.

Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial.

VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma.